Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001437749-21-027339

Pres. Diagnostics & Genom sold 500 shares at an average $505.38 ($252,689)

  • Pres. Diagnostics & Genom acquired 500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2021-11-19 Option exercise +500 $150.78 $75,390 500 D
Kelderman Kim Pres. Diagnostics & Genom 2021-11-19 Sale −100 $503.76 $50,376 400 D
Kelderman Kim Pres. Diagnostics & Genom 2021-11-19 Sale −400 $505.78 $202,313 0 D
Derivatives
Kelderman Kim Pres. Diagnostics & Genom 2021-11-19 Option exercise · Stock Option (Right to Buy) −500 2,152 D
Open-market sales · 500 sh · avg $505.38 · $252,689
Loading xslF345X03/rdgdoc.xml…